Skip to main content Skip to secondary navigation

Docket #: S22-479

A digital health solution for remote assessment of allergic contact dermatitis

Stanford researchers have designed a remote digital health platform to assist diagnosis and management of some inflammatory skin conditions, such as eczema. It allows screening for contact allergies by using a new transdermal adhesive device to deliver contact allergens and carry out epicutaneous patch tests paired with a digital platform and a trained neural network for interpretation of results by using digital images.

This test kit enables testing in a remote setting, such as in a home or a primary care facility rather than in a specialty clinic. This system and method include -an adhesive device, a software, algorithms, and communication tools which detects and interprets skin reactions to allergens using digital images.

Stage of Development

  • Prototype for the adhesive device in early production. Pilot clinical study on self-application of allergen panels in progress with promising results. Image library expansion in progress.
  • Applications

    • Digital Platform for assessing inflammatory skin conditions, such as eczema"
    • Remote testing kit that can be administered at home or at a primary care facility or pharmacy

    Advantages

    • Cost effective and convenient - Can be administered at home or in primary care facility rather than in a specialty clinic
    • Improves access to care
    • Waterproof allergen panels unlike current panels which require users to refrain from bathing for periods of time (typically 4 days)

    Patents

    Similar Technologies

    Explore similar technologies by keyword: